For instance, CD105, a marker for proliferating endothelial cells and neoangiogenesis, was found to be an independent prognostic factor for tumor progression and survival in women with advanced EOCs after adjusting for prognostic clinical covariates; however, such an association was not observed between CD31, a pan-endothelial marker, and tumor progression and survival (28). The gene discussed is PECAM1; the disease is neoplasm.